Paper18829751
Glycosylation of gp41 of simian immunodeficiency virus shields epitopes that can be targets for neutralizing antibodies.
Yuste E and 5 others. J Virol, 2008. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Glycosylation of gp41 of simian immunodeficiency virus shields epitopes that can be targets for neutralizing antibodies. Papers, record 18829751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18829751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Viral | Major topic |
| Epitopes | Major topic |
| Gene Products, env | Major topic |
| Simian Immunodeficiency Virus | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Cell Line | |
| Cell Membrane | |
| Conserved Sequence | |
| Evolution, Molecular | |
| Glycosylation | |
| Humans | |
| Kinetics | |
| Macaca mulatta | |
| Molecular Sequence Data | |
| Mutation | |
| Sequence Alignment | |
| Virus Replication |
Source PubMed
Grants15
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI057039 | NIAID NIH HHS | United States | R01AI057039 | PubMed and NIH | NIH RePORTER |
| RR00168 | NCRR NIH HHS | United States | K26RR000168 | PubMed and NIH | NIH RePORTER |
| R37 AI025328 | NIAID NIH HHS | United States | R01AI025328 | PubMed and NIH | NIH RePORTER |
| R01 AI025328 | NIAID NIH HHS | United States | R01AI025328 | PubMed and NIH | NIH RePORTER |
| N01 CO012400 | NCI NIH HHS | United States | N01CO012400 | PubMed | NIH RePORTER |
| AI150421 | NIAID NIH HHS | United States | PubMed | PubMed | |
| AI025328 | NIAID NIH HHS | United States | R01AI025328 | PubMed and NIH | NIH RePORTER |
| AI057039 | NIAID NIH HHS | United States | R01AI057039 | PubMed and NIH | NIH RePORTER |
| N01-CO-12400 | NCI NIH HHS | United States | PubMed | PubMed | |
| P51 RR000168 | NCRR NIH HHS | United States | K26RR000168 | PubMed and NIH | NIH RePORTER |
| K26 RR000168 | NCRR NIH HHS | United States | K26RR000168 | PubMed and NIH | NIH RePORTER |
| P06RR000168 | NIH | NIH RePORTER | |||
| P40RR000168 | NIH | NIH RePORTER | |||
| P51RR000168 | NIH | NIH RePORTER | |||
| R37AI025328 | NIH | NIH RePORTER |
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10888615 | V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies. | J Virol | 2000 | https://conductscience.org/library/papers/10888615 | PubMed |
| 2 | 9623976 | A role for carbohydrates in immune evasion in AIDS. | Nat Med | 1998 | https://conductscience.org/library/papers/9623976 | PubMed |
| 3 | 11070015 | Resistance of native, oligomeric envelope on simian immunodeficiency virus to digestion by glycosidases. | J Virol | 2000 | https://conductscience.org/library/papers/11070015 | PubMed |
| 4 | 11160699 | Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3). | J Virol | 2001 | https://conductscience.org/library/papers/11160699 | PubMed |
| 5 | 11160708 | Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants. | J Virol | 2001 | https://conductscience.org/library/papers/11160708 | PubMed |
| 6 | 11238869 | Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops. | J Virol | 2001 | https://conductscience.org/library/papers/11238869 | PubMed |
| 7 | 11293117 | The antiviral activity of antibodies in vitro and in vivo. | Adv Immunol | 2001 | https://conductscience.org/library/papers/11293117 | PubMed |
| 8 | 11448167 | Characterization of the cis-acting elements controlling subgenomic mRNAs of citrus tristeza virus: production of positive- and negative-stranded 3'-terminal and positive-stranded 5'-terminal RNAs. | Virology | 2001 | https://conductscience.org/library/papers/11448167 | PubMed |
| 9 | 11581387 | Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment. | J Virol | 2001 | https://conductscience.org/library/papers/11581387 | PubMed |
| 10 | 11689624 | Conserved, N-linked carbohydrates of human immunodeficiency virus type 1 gp41 are largely dispensable for viral replication. | J Virol | 2001 | https://conductscience.org/library/papers/11689624 | PubMed |
| 11 | 11932385 | Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response. | J Virol | 2002 | https://conductscience.org/library/papers/11932385 | PubMed |
| 12 | 12477842 | Importance of B-cell responses for immunological control of variant strains of simian immunodeficiency virus. | J Virol | 2003 | https://conductscience.org/library/papers/12477842 | PubMed |
| 13 | 12646921 | Antibody neutralization and escape by HIV-1. | Nature | 2003 | https://conductscience.org/library/papers/12646921 | PubMed |
| 14 | 12941910 | Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities. | J Virol | 2003 | https://conductscience.org/library/papers/12941910 | PubMed |
| 15 | 15016849 | N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies. | J Virol | 2004 | https://conductscience.org/library/papers/15016849 | PubMed |
| 16 | 2538547 | Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis. | J Exp Med | 1989 | https://conductscience.org/library/papers/2538547 | PubMed |
| 17 | 1548752 | Complex determinants of macrophage tropism in env of simian immunodeficiency virus. | J Virol | 1992 | https://conductscience.org/library/papers/1548752 | PubMed |
| 18 | 1515210 | Study of the interaction of HIV-1 and HIV-2 envelope glycoproteins with the CD4 receptor and role of N-glycans. | AIDS Res Hum Retroviruses | 1992 | https://conductscience.org/library/papers/1515210 | PubMed |
| 19 | 8317093 | Evidence for the cooperation of gp120 amino acids 322 and 448 in SIVmac entry. | Virology | 1993 | https://conductscience.org/library/papers/8317093 | PubMed |
| 20 | 8122371 | An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization. | Virology | 1994 | https://conductscience.org/library/papers/8122371 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34830279 | A Comprehensive Analysis of Human Endogenous Retroviruses HERV-K (HML.2) from Teratocarcinoma Cell Lines and Detection of Viral Cargo in Microvesicles. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34830279 | PubMed |
| 32256496 | Long-Term Delivery of an Anti-SIV Monoclonal Antibody With AAV. | Front Immunol | 2020 | https://conductscience.org/library/papers/32256496 | PubMed |
| 30814513 | Rationally designed carbohydrate-occluded epitopes elicit HIV-1 Env-specific antibodies. | Nat Commun | 2019 | https://conductscience.org/library/papers/30814513 | PubMed |
| 30566493 | Guiding the humoral response against HIV-1 toward a MPER adjacent region by immunization with a VLP-formulated antibody-selected envelope variant. | PLoS One | 2018 | https://conductscience.org/library/papers/30566493 | PubMed |
| 29343575 | High-Resolution Sequencing of Viral Populations during Early Simian Immunodeficiency Virus Infection Reveals Evolutionary Strategies for Rapid Escape from Emerging Env-Specific Antibody Responses. | J Virol | 2018 | https://conductscience.org/library/papers/29343575 | PubMed |
| 28747495 | Human Immunodeficiency Virus and Simian Immunodeficiency Virus Maintain High Levels of Infectivity in the Complete Absence of Mucin-Type O-Glycosylation. | J Virol | 2017 | https://conductscience.org/library/papers/28747495 | PubMed |
| 23616655 | Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design. | J Virol | 2013 | https://conductscience.org/library/papers/23616655 | PubMed |
| 22993152 | Neutralizing capacity of monoclonal antibodies that recognize peptide sequences underlying the carbohydrates on gp41 of simian immunodeficiency virus. | J Virol | 2012 | https://conductscience.org/library/papers/22993152 | PubMed |
| 22933282 | A novel assay for antibody-dependent cell-mediated cytotoxicity against HIV-1- or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assays. | J Virol | 2012 | https://conductscience.org/library/papers/22933282 | PubMed |
| 22072749 | Evidence against extracellular exposure of a highly immunogenic region in the C-terminal domain of the simian immunodeficiency virus gp41 transmembrane protein. | J Virol | 2012 | https://conductscience.org/library/papers/22072749 | PubMed |
| 21909262 | Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies. | PLoS Pathog | 2011 | https://conductscience.org/library/papers/21909262 | PubMed |
| 21165339 | Functional contributions of carbohydrate on AIDS virus glycoprotein. | Yale J Biol Med | 2010 | https://conductscience.org/library/papers/21165339 | PubMed |
| 21067547 | Models of RNA virus evolution and their roles in vaccine design. | Immunome Res | 2010 | https://conductscience.org/library/papers/21067547 | PubMed |
| 20702641 | Envelope-modified single-cycle simian immunodeficiency virus selectively enhances antibody responses and partially protects against repeated, low-dose vaginal challenge. | J Virol | 2010 | https://conductscience.org/library/papers/20702641 | PubMed |
| 20610711 | Fundamental difference in the content of high-mannose carbohydrate in the HIV-1 and HIV-2 lineages. | J Virol | 2010 | https://conductscience.org/library/papers/20610711 | PubMed |
| 20055586 | Short communication: Simultaneous substitutions of V38M and N43T-N44K in the gp41 heptad repeat 1 (HR1) disrupt HIV type 1 gPr160 endoproteolytic cleavage (*). | AIDS Res Hum Retroviruses | 2010 | https://conductscience.org/library/papers/20055586 | PubMed |
| 19610667 | Glycosylation site-specific analysis of clade C HIV-1 envelope proteins. | J Proteome Res | 2009 | https://conductscience.org/library/papers/19610667 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18829751
GET https://conductscience.org/api/papers/v1/18829751/references?page=2